Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models [PDF]
Background/Purpose Localized scleroderma (LS) is a rare disease leading to progressive hardening and induration of the skin and subcutaneous tissues. LS is responsive to UVA-1 phototherapy, though its exact mechanism of action dermal fibrosis is yet to ...
Carraro, Andrea+6 more
core +1 more source
The Videofluorographic Swallowing Study in Rheumatologic Diseases: A Comprehensive Review [PDF]
Autoimmune connective tissue diseases are a heterogeneous group of pathologies that affect about 10% of world population with chronic evolution in 20%-80%.
Costanzo, M.+13 more
core +3 more sources
The Role of Abatacept on Inflammation and Fibrosis in Hypochlorous Acid‐Induced Fibrosis Mice
ABSTRACT Aim To investigate the effect of abatacept in the hypochlorous acid (HCLO)‐induced fibrosis model and to analyze changes in immune cell fractions within the abatacept‐treated early diffuse systemic sclerosis (SSc) cohort. Methods Fibrosis was induced in BALB/c mice by subcutaneous injection of HCLO, and abatacept was injected intraperitoneally
Bingying Dai+14 more
wiley +1 more source
Scalable Collaborative Infrastructure for a Learning Healthcare System (SCILHS): Architecture [PDF]
We describe the architecture of the Patient Centered Outcomes Research Institute (PCORI) funded Scalable Collaborative Infrastructure for a Learning Healthcare System (SCILHS, http://www.SCILHS.org) clinical data research network, which leverages the $48
Adams, William G+20 more
core +2 more sources
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
1. In theory, CAR‐engineering therapy can achieve therapeutic effects by targeting cells expressing specific antigens and thereby eliminating or regulating disease‐related cell subpopulations. 2. Although CAR‐engineering therapy is currently only approved for the treatment of cancer, it has also shown potential in non‐tumour diseases. 3.
Lvying Wu, Lingfeng Zhu, Jin Chen
wiley +1 more source
Сучасні аспекти патогенетичної терапії хворих на склеродермію. Огляд літератури [PDF]
Дані літератури свідчать, що традиційні лікарські препарати у хворих на склеродермію ефективні далеко не завжди; багато з них спричиняють різні побічні реакції, що обумовлює пошук принципово нових терапевтичних технологій, у тому числі – з використанням ...
Горбунцов, В.В.+2 more
core
Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis [PDF]
journal ...
73107+11 more
core +1 more source
Objective Primary antiphospholipid syndrome (PAPS) is a rare autoimmune disease characterized by the presence of antiphospholipid antibodies and the occurrence of thrombotic events and pregnancy complications. Our study aimed to identify novel genetic susceptibility loci associated with PAPS.
Desiré Casares‐Marfil+89 more
wiley +1 more source
Disabling pansclerotic morphea of childhood with extracutaneous manifestations
Disabling pansclerotic morphea (DPM) of childhood is a rare generalized type of localized scleroderma (LS) that is known to follow an aggressive course with pansclerotic lesions leading to severe joint contractures and consequent immobility. Mortality is
Mahendra M Kura, Saurabh R Jindal
doaj +1 more source
Intravenous treatment of calcinosis cutis with sodium thiosulfate – A case series
Summary Calcinosis cutis is defined as the deposition of calcium salts in the skin. The dystrophic form is the most common and usually occurs in chronic inflammatory processes associated with collagenoses. Therapeutic options include surgical excision as well as a few pharmacological treatments.
Tom Bruns+2 more
wiley +1 more source